Qube Research & Technologies (QRT)
STRO icon

Qube Research & Technologies (QRT)’s Sutro Biopharma STRO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,523
Closed -$56.6K – 4067
2025
Q3 		$56.6K Sell
6,523
-5,017
-43% -$42.7K ﹤0.01% 3164
2025
Q2 		$82.4K Buy
+11,540
New +$94.4K ﹤0.01% 3068
2024
Q4 		– Sell
-6,890
Closed -$238K – 3800
2024
Q3 		$238K Sell
6,890
-171
-2% -$6.7K ﹤0.01% 2521
2024
Q2 		$207K Buy
+7,061
New +$279K ﹤0.01% 2416
2023
Q4 		– Sell
-495
Closed -$17.2K – 4712
2023
Q3 		$17.2K Buy
+495
New +$21.6K ﹤0.01% 3193
2023
Q2 		– Sell
-3,963
Closed -$183K – 2989
2023
Q1 		$183K Buy
+3,963
New +$251K ﹤0.01% 1961
2022
Q3 		– Sell
-2,930
Closed -$153K – 3009
2022
Q2 		$153K Buy
+2,930
New +$164K ﹤0.01% 1803
2022
Q1 		– Sell
-1,009
Closed -$150K – 2983
2021
Q4 		$150K Buy
+1,009
New +$181K ﹤0.01% 2051
2021
Q3 		– Sell
-1,534
Closed -$285K – 2747
2021
Q2 		$285K Buy
1,534
+389
+34% +$76.1K ﹤0.01% 1608
2021
Q1 		$261K Buy
+1,145
New +$272K ﹤0.01% 1526

Other funds holding STRO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Qube Research & Technologies (QRT)'s STRO Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Sutro Biopharma (STRO) in Q4 2025, closing a stake of 6,523 shares — an estimated $56.6K sold.

Qube Research & Technologies (QRT) first reported a position in STRO in Q1 2021 and held it in 10 quarters. The position peaked at $285K in Q2 2021. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Sutro Biopharma position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 6,523 Sutro Biopharma shares in Q4 2025, an estimated $56.6K.
  • Qube Research & Technologies (QRT) first reported a position in Sutro Biopharma in Q1 2021 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Sutro Biopharma position peaked at $285K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.